An Overview on Hyperlipidemia

D. A. Helen Sheeba *

Department of Pharmaceutical Chemistry and Analysis, School of Pharmaceutical Science, Vels Institute of Science, Technology and Advanced studies (VISTAS), Pallavaram, Chennai-600 177, Tamil Nadu, India.

R. Gandhimathi

Department of Pharmaceutical Chemistry and Analysis, School of Pharmaceutical Science, Vels Institute of Science, Technology and Advanced studies (VISTAS), Pallavaram, Chennai-600 177, Tamil Nadu, India.

*Author to whom correspondence should be addressed.


Abstract

Introduction: Hyperlipidemia is a medical condition indicated by an increase in one or more plasma lipids, such as triglycerides, cholesterol, cholesterol esters, phospholipids, and/or plasma lipoproteins, such as very low-density lipoprotein and low-density lipoprotein, as well as decreased levels of high-density lipoprotein. This increase in plasma lipids is one of the most important risk factors for cardiovascular disease. In the meanwhile, statins and fibrates remain the most common anti-hyperlipidemic drugs for treating high plasma cholesterol and triglycerides.

Conclusion: Hence this review focused to study of hyperlipidemia. This review is useful to research work in hyperlididemia.

Keywords: hyperlipidemia, lipid transport, cholesterol, dietary plant fibers, hypolipidemic drugs


How to Cite

Sheeba, D. A. H. and Gandhimathi, R. (2021) “An Overview on Hyperlipidemia”, Journal of Pharmaceutical Research International, 33(59B), pp. 543–555. doi: 10.9734/jpri/2021/v33i59B34413.